• Citer

The feasibility of classical cyclophophamide, methotrexate, 5-fluorouracil (CMF) for pre- and post-menopausal node-positive breast cancer patients in a Belgian multicentric trial: A study of consistency in relative dose intensity (RDI) and cumulative doses across institutions

par Ferreira Filho, Antonio Fabiano ;Di Leo, Angelo ;Paesmans, Marianne ;Beauduin, Marc;Vindevoghel, Anita;Michel, Jeffrey;Focan, Christian;Awada, Ahmad ;Cardoso, Fatima ;Dolci, Stella;Bartholomeus, Sylvie;Piccart-Gebhart, Martine
Référence Annals of oncology, 13, 3, page (416-421)
Publication Publié, 2002

Article révisé par les pairs

• Accès en ligne
• Détails
• Statistiques

Titre:	The feasibility of classical cyclophophamide, methotrexate, 5-fluorouracil (CMF) for pre- and post-menopausal node-positive breast cancer patients in a Belgian multicentric trial: A study of consistency in relative dose intensity (RDI) and cumulative doses across institutions
Auteur:	Ferreira Filho, Antonio Fabiano; Di Leo, Angelo; Paesmans, Marianne; Beauduin, Marc; Vindevoghel, Anita; Michel, Jeffrey; Focan, Christian; Awada, Ahmad; Cardoso, Fatima; Dolci, Stella; Bartholomeus, Sylvie; Piccart-Gebhart, Martine
Informations sur la publication:	Annals of oncology, 13, 3, page (416-421)
Statut de publication:	Publié, 2002
Sujet CREF:	Cancérologie
	Sciences bio-médicales et agricoles
Mots-clés:	Adjuvant chemotherapy
	Breast cancer
	Classical CMF
	Feasibility
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0923-7534
	info:doi/10.1093/annonc/mdf051
	info:scp/0036018905